N-acylethanolamines and precursor phospholipids - Relation to cell injury

Chemistry and Physics of Lipids

Volumn 108, Issue 1-2, 2000, Pages 135-150

  Hansen, Harald S ^a   Moesgaard, Birthe ^a   Hansen, Henrik H ^a   Petersen, Gitte ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Anandamide; Injury; N acylethanolamine; N acylethanolamine phospholipid; N acylethanolamine phospholipid hydrolyzing phospholipase D; N acyltransferase

Indexed keywords

ACYLSPHINGOSINE DEACYLASE; ANANDAMIDE; CALCIUM; CANNABINOID RECEPTOR; ETHANOLAMINE DERIVATIVE; N ACYLETHANOLAMINE; N ACYLPHOSPHATIDYLETHANOLAMINE; PHOSPHOLIPASE D; PHOSPHOLIPID; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; BRAIN INJURY; CALCIUM TRANSPORT; CELL PROTECTION; ENZYME INHIBITION; HEART INJURY; HUMAN; MEMBRANE STABILIZATION; MITOCHONDRIAL MEMBRANE; NONHUMAN; PHOSPHOLIPID SYNTHESIS; PRIORITY JOURNAL; RECEPTOR BINDING; REVIEW; TESTIS INJURY; TISSUE DISTRIBUTION;

ANIMALS; ETHANOLAMINE; OXIDATIVE STRESS;

EID: 0033661848     PISSN: 00093084     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-3084(00)00192-4     Document Type: Review

References (125)

1. A phosphorus magnetic resonance spectroscopy and a differential scanning calorimetry study of the physical properties of N-acylphosphatidylethanolamines in aqueous dispersions
2. A proposed autacoid mechanism controlling mastocyte behaviour
3. Effects of the endogeneous cannabinoid, anandamide, on neuronal activity in rat hippocampal slices
4. Coupled inositide phosphorylation and phospholipase D activation initiates clathrin-coat assembly on lysosomes
5. Glutamate neurotoxicity in rat cerebellar granule cells involves cytochrome c release from mitochondria and mitochondrial shuttle impairment
6. Cannabinomimetic behavioral effects of and adenylate cyclase inhibition by two new endogenous anandamides
7. Chronic ethanol increases the cannabinoid receptor agonist anandamide and its precursor N-arachidonoylphosphatidylethanolamine in SK-N-SH cells
8. Functional role of high-affinity anandamide transport, as revealed by selective inhibition
9. Analysis of cannabinoid receptor binding and mRNA expression and endogenous cannabinoid contents in the developing rat brain during late gestation and early postnatal period
10. Biosynthesis, uptake, and degradation of anandamide and palmitoylethanolamide in leukocytes
11. Brain regional distribution of endocannabinoids: Implications for their biosynthesis and biological function
12. Biosynthesis and inactivation of N-arachidonoylethanolamine (anandamide) and N-docosahexaenoylethanolamine in bovine retina
13. The stimulation of ketogenesis by cannabinoids in cultured astrocytes defines carnitine palmitoyltransferase I as a new ceramide-activated enzyme
14. Dietary linoleic acid and polyunsaturated fatty acids in rat brain and other organs. Minimal requirements of linoleic acid
15. Membrane localization of N-acylphosphatidylethanolamine in central neurons: Studies with exogenous phospholipases
16. Biosynthesis of an endogenous cannabinoid precursor in neurons and its control by calcium and cAMP
17. Occurrence and biosynthesis of endogenous cannabinoid precursor, N-arachidonoyl phosphatidylethanolamine, in rat brain
18. Control of pain initiation by endogenous cannabinoids
19. Oxidative stress, mitochondrial function, and acute glutamate excitotoxicity in cultured cerebellar granule cells
20. Catalytic properties of a newly discovered acyltransferase that synthesizes N-acylphosphatidylethanolamine in cottonseed (Gossypium hisutum L.) microsomes
21. Cannabis and endogenous cannabinoid systems
22. Control of arachidonate levels within inflammatory cells
23. Phospholipase D, tumor promoters, proliferation and prostaglandins
24. Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist
25. Production and physiological actions of anandamide in the vasculature of the rat kidney
26. Relation between free fatty acid and acyl-CoA concentrations in rat brain following decapitation
27. Isolation and structure of a brain constituent that binds to the cannabinoid receptor
28. Phosphatidic acid: A potential signal transducer for cardiac hypertrophy
29. Formation and inactivation of endogenous cannabinoid anandamide in central neurons
30. 'Endocannabinoids' and other fatty acid derivatives with cannabimimetic properties: Biochemistry and possible physiopathological relevance
31. Biosynthesis and inactivation of endocannabinoids: Relevance to their proposed role as neuromodulators
32. 9-tetrahydrocannabinol-tolerant rats
33. Role of headgroup structure in the phase behaviour of N-acylethanolamine phospholipids: Hydrogen-bonding ability and headgroup size
34. Inflammatory mechanisms in Alzheimer's disease
35. N-Acylethanolamine accumulation in infarcted myocardium
36. Accumulation of N-acylethanolamine glycerophospholipids in infarcted myocardium
37. 2+ release from mitochondria by N-acylethanolamines, a class of lipids synthesized in ischemic heart tissue
38. Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide
39. Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and rat
40. Mammalian phospholipase D structure and regulation
41. Isotope dilution GC/MS determination of anandamide and other fatty acylethanolamides in rat blood plasma
42. Dopamine activation of endogenous cannabinoid signaling in dorsal striatum
43. Identification of endocannabinoids and cannabinoid CB1 receptor mRNA in the pituitary gland
44. Changes in lipid composition of neuroblastoma C1300 N18 cell during differentiation
45. Long-chain N-acylethanolamines inhibit lipid peroxidation in rat liver mitochondria under acute hypoxic hypoxia
46. Electrospray ionization mass spectrometric method for the determination of cannabinoid precursors: N-acylethanolamine phospholipids (NAPEs)
47. Determination of the phospholipid precursor of anandamide and other N-acylethanolamine phospholipids before and after sodium azide-induced toxicity in cultured neocortical neurons
48. Glutamate stimulates the formation of N-acylphosphatidylethanolamine and N-acylethanolamine in cortical neurons in culture
49. Characterization of glutamate-induced formation of N-acylphosphatidylethanolamine and N-acylethanolamine in cultured neocortical neurons
50. Formation of N-acyl-phosphatidylethanolamines and N-acylethanolamines-proposed role in neurotoxicity
51. 2-induced formation of N-acylethanolamine phospholipids (NAPE) and N-acylethanolamine (NAE) in cortical neurons
52. Formation of N-acyl-phosphatidylethanolamine and N-acylethanolamine (including anandamide) during glutamate-induced neurotoxicity
53. Two new unsaturated fatty acid ethanolamides in brain that bind to the cannabinoid receptor
54. Biochemistry and pharmacology of arachidonylethanolamide, a putative endogenous cannabinoid
55. Accumulation of N-arachidonoylethanolamine (anandamide) into cerebellar granule cells occurs via facilitated diffusion
56. Delayed phospholipid degradation in rat brain after traumatic brain injury
57. Nitric oxide donors induce stress signaling via ceramide formation in rat renal mesangial cells
58. Equilibrium in the hydrolysis and synthesis of cannabimimetic anandamide demonstrated by a purified enzyme
59. Isotope dilution mass spectrometric measurements indicate that arachidonylethanolamide, the proposed endogenous ligand of the cannabinoid receptor, accumulates in rat brain tissue post mortem but is contained at low levels in or is absent from fresh tissue
60. Lipid dynamics and peripheral interactions of proteins with membrane surfaces
61. Liquid chromatographic-atmospheric pressure chemical ionization mass spectrometric determination of anandamide and its analogs in rat brain and peripheral tissues
62. Accumulation of various N-acylethanolamines including N-arachidonoylethanolamine (anandamide) in cadmium chloride-administered rat testis
63. Alterations of fatty acyl turnover in macrophage glycerolipids induced by stimulation. Evidence for enhanced recycling of arachidonic acid
64. Biosynthesis and turnover of anandamide and other N-acylethanolamines in peritoneal macrophages
65. Elevated endogenous cannabinoids in schizophrenia
66. Discovery and characterization of endogenous cannabinoids
67. N-(2-Hydroxyethyl)hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by down-modulating mast cell activation
68. Enzymology of cottonseed microsomal N-acylphosphatidylethanolamine synthase: Kinetic properties and mechanism-based inactivation
69. Activation of phospholipase D in human fibroblasts by ceramide and sphingosine: Evaluation of their modulatory role in bradykinin stimulation of phospholipase D
70. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors
71. Endocannabinoids
72. 31P NMR study
73. 31P NMR and enzyme activity study
74. Anandamide suppresses nitric oxide and TNF-α responses to Theiler's virus or endotoxin in astrocytes
75. Cannabinoids and neuroprotection in global and focal cerebral ischemia and in neuronal cultures
76. On the biosynthesis and metabolism of N-acylethanolamine phospholipids in infarcted dog heart
77. N-Acylation of ethanolamine phospholipids in canine myocardium
78. Biosynthesis of N-acylethanolamine phospholipids by dog brain preparations
79. Catabolism of N-acylethanolamine phospholipids by dog brain preparations
80. N-Acylethanolamine phospholipid metabolism in normal and ischemic rat brain
81. Phase behaviour of synthetic N-acylethanolamine phospholipids
82. Purification, characterization, and sequence determination of phospholipase D secreted by Streptoverticillium cinnamoneum
83. The uterus is a potential site for anandamide synthesis and hydrolysis: Differential profiles of anandamide synthase and hydrolase activities in the mouse uterus during the periimplantation period
84. Effects of long-chain N-acylethanolamines on lipid peroxidation in cardiac mitochondria
85. Chemical and mutagenic investigations of fatty acid amide hydrolase: Evidence for a family of serine hydrolases with distinct catalytic properties
86. Effects of two endogenous fatty acid ethanolamides on mouse vasa deferentia
87. N-acylphosphatidylethanolamine-hydrolysing phospholipase D lacks the ability to transphosphatidylate
88. A rapid phospholipase D assay using zirconium precipitation of anionic substrate phospholipids: Application to N-acylethanolamine formation in vitro
89. Ceramide can induce cell death in sensory neurons, whereas ceramide analogues and sphingosine promote survival
90. Structural determinants for recognition and translocation by the anandamide transporter
91. Cannabinoids inhibit LPS-inducible cytokine mRNA expression in rat microglial cells
92. Endocannabinoids: A new class of vasoactive substances
93. The role of cardiolipin as an acyl donor in dog heart N-acylethanolamine phospholipid biosynthesis
94. N-Acylation of dog heart ethanolamine phospholipids by transacylase activity
95. Properties of canine myocardial phosphatidylethanolamine N-acyltransferase
96. Phospholipase D and its product, phosphatidic acid, mediate agonist-dependent Raf-1 translocation to the plasma membrane and the activation of the mitogen-activated protein kinase pathway
97. N-Arachidonylethanolamine (anandamide) formation from N-arachidonylphosphatidylethanolamine in rat brain membranes
98. N-Acylated glycerophospholipids and their derivatives
99. The N-acylation-phosphodiesterase pathway and cell signalling
100. Metabolism of N-acylethanolamine phospholipids by mammalian phosphodiesterase of the phospholipase D type
101. Occurrence and postmortem generation of anandamide and other long-chain N-acylethanolamines in mammalian brain
102. Corrigendum to: Occurrence and postmortem generation of anandamide and other long-chain N-acylethanolamines in mammalian brain
103. Changes in anandamide levels in mouse uterus are associated with uterine receptivity for embryo implantation
104. Cannabinoid receptor agonists protect cultured rat hippocampal neurons from excitotoxicity
105. 9-tetrahydrocannabinol acts as a partial agonist to modulate glutamatergic synaptic transmission between rat hippocampal neurons in culture
106. The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons
107. Mast cell activation causes delayed neurodegeneration in mixed hippocampal cultures via the nitric oxide pathway
108. N-oleoylethanolamine inhibits glucosylation of natural ceramides in CHP-100 neuroepithelioma cells: Possible implications for apoptosis
109. Characterization of human PLD2 and the analysis of PLD isoform splice variants
110. Cannabinoid CB1 receptors and ligands in vertebrate retina: Localization and function of an endogenous signaling system
111. Ceramidase deficiency in Farber's disease
112. 2-Arachidonoylgylcerol: A possible endogenous cannabinoid receptor ligand in brain
113. 2+-dependent transacylase and phosphodiesterase activities
114. Transacylase-mediated and phosphodiesterase-mediated synthesis of N-arachidonoylethanolamine, an endogenous cannabinoid-receptor ligand, in rat brain microsomes-comparison with synthesis from free arachidonic acid and ethanolamine
115. Evidence that the cannabinoid CB1 receptor is a 2-arachidonoylglycerol receptor-Structure-activity relationship of 2-arachidonoylglycerol ether-linked analogues, and related compounds
116. Phospholipase D-derived phosphatidic acid is involved in the activation of the CD11b/CD18 integrin in human eosinophils
117. An acid amidase hydrolyzing anandamide as an endogenous ligand for cannabinoid receptors
118. (R)-methanandamide inhibits receptor-induced calcium responses by depleting internal calcium stores in cultured astrocytes
119. The PLD superfamily: Insights into catalysis
120. Pain modulation by release of the endogenous cannabinoid anandamide
121. Staurosporine induces programmed cell death in embryonic neurons and activation of the ceramide pathway
122. Programmed cell death in neurotumour cells involves the generation of ceramide
123. Anti-immunoglobulin-induced apoptosis in WEHI 231 cells involves the slow formation of ceramide from sphingomyelin and is blocked by bcl-X(L)
124. GC/MS analysis of anandamide and quantification of N-arachidonoylphosphatidylethanolamides in various brain regions, spinal cord, testis, and spleen of the rat
125. The transphosphatidylation activity of phospholipase D